Sharp Therapeutics Corp. (TSX-V: SHRX) (OTCQB: SHRXF) announced preclinical data showing its small-molecule compounds reduced cholesterol accumulation in cells from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE